Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
In-licensing

Late stage products in CNS, immunology, infectious disease and dermatology areas

Astellas Pharma Taiwan wishes to in-license branded ethical drugs for the Taiwanese market

Full description

Astellas Pharma Taiwan, Inc, is committed to attentive partnering for commercial success by in-licensing in key indication areas for the Taiwanese market : -Urology disease - any late stage or currently marketed products. - Central nervous system: any late stage or currently marketed products. -Immunology: any late stage or currently marketed products. -Infectious disease: any late stage or currently marketed products. -Dermatology: any late stage or currently marketed products.

Development status

Phase III/IV

Type of business relationship sought

Licensing late stage or marketed prescription products for the Taiwanese market. Areas of interest include:

- Urology

- Central nervous system

- Immunology

- Infectious disease

- Dermatology

- Other niche markets.

Licensing contact

Mrs Frances Lin
Project Manager
Marketing Dept
Request more information

Company details

Astellas Pharma Taiwan, Inc (formerly Fujisawa Taiwan Co. Ltd)
Astellas Pharma Taiwan Inc, is the leading Japanese Pharmaceutical Co. with a successful record. We wish to in-license branded ethical drugs for the Taiwan market.

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Partnering consultation free of charge
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us